Quanterix Launches LucentAD Biomarker Blood Test to Aid Physician Diagnosis of Alzheimer’s Disease in Patients

Test will play an important role in the evaluation of patients experiencing cognitive symptoms consistent with early signs of Alzheimer’s disease BILLERICA, Mass. -- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced it has launched LucentAD, a test to assist in the evaluation of patients [...]

Thermo Fisher Scientific to Acquire CorEvitas

Advances World-Class Clinical Research Capabilities with Leading Regulatory-Grade Registries Platform Expected to Be Immediately Accretive to Adjusted Earnings Per Share 1 WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced it has entered into a definitive agreement to acquire CorEvitas, LLC (“CorEvitas”), a leading provider of [...]

Twist Bioscience DNA-Based Tools Now Available in Ireland From MyBio

KILKENNY, Ireland & SAN FRANCISCO -- MyBio, the life science solutions provider, KILKENNY, Ireland, announces an exclusive distribution agreement with Twist Bioscience, SAN FRANCISCO, United States, bringing its synthetic DNA and next-generation sequencing products to the Irish market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230705077855/en/ This partnership enables the extension of Twist’s reach [...]

INOVIQ and Promega announce global joint marketing agreement for EXO-NET exosome isolation and nucleic acid purification solutions

INOVIQ and Promega sign a global joint marketing agreement for INOVIQ’s EXO-NET® exosome capture technology and Promega Nucleic Acid purification systems Initial deal enables co-marketing of both INOVIQ and Promega products to deliver exosome solutions to global customers for manual and high-throughput exosome isolation and nucleic acid extraction Agreement expected to deliver world-class exosome tools [...]

Qkine and Sartorius partnership delivers a complete workflow solution for the analysis of advanced cell models

Sartorius to commercialize Qkine growth factors and cytokines as part of a complete workflow solution for stem cell and organoid research Cell type-specific application data on Sartorius instruments streamline process and speed up time to results This collaboration supports a larger initiative to enable rapid advancement in the science of advanced cell models   Cambridge, [...]

Hitachi forms strategic research collaboration with Mass General Brigham in the field of regenerative medicine and GCT

Harnessing its automated cell culturing and digital technology to overcome intractable diseases Tokyo – Hitachi, Ltd. (TSE: 6501, "Hitachi") announced that it has entered a strategic framework collaboration agreement with the world-renowned medical research institution, Brigham and Women's Hospital (BWH), a founding member of the Mass General Brigham healthcare system and a teaching affiliate of [...]

GenScript Doubles cGMP sgRNA and Non-Viral DNA Payload Manufacturing Capacity

Additional 400,000 sq.ft. at GenScript's cGMP facility in Zhenjiang, China gives biopharma companies and gene/cell therapeutic discovery startups fast access to synthetic CRISPR sgRNA and non-viral single and double-stranded DNA payloads PISCATAWAY, N.J. -- GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has expanded its cGMP manufacturing capacity for sgRNA [...]

MGI’s DNBSEQ-T7* Receives Approval for Clinical Use in South Korea

Seoul, South Korea - MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, announced its ultra-high-throughput genetic sequencer DNBSEQ-T7 received the medical device registration certificate from the Korea Ministry of Food and Drug Safety (MFDS). This marks another significant step for MGI into the South Korean market [...]

Centre Hospitalier de Bastia is Live on SOPHiA GENETICS

SOPHiA DDMTM Platform will bring next-generation sequencing in-house and help further research on hematologic malignancies BOSTON and ROLLE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Centre Hospitalier de Bastia is live on the SOPHiA DDM™ Platform. Centre Hospitalier de Bastia, a general hospital located in the city [...]

QIAGEN expands next-generation sequencing portfolio with QIAseq Normalizer kits

QIAGEN expands next-generation sequencing portfolio with QIAseq Normalizer kits Normalizes various library types over a broad range of concentrations in only 30 minutes QIAseq kits have processed more than four million NGS samples Venlo, the Netherlands – QIAGEN today announced the launch of the QIAseq Normalizer Kits that give researchers a fast, convenient and cost-effective [...]

Access IBO on Knowledge Center